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Abstract
To identify critical host factors necessary for human immunodeficiency virus 1 (HIV-1) replication, large libraries of short-
peptide-aptamers were expressed retrovirally. The target of one inhibitor peptide, Pep80, identified in this screen was
determined to be Snapin, a protein associated with the soluble N-ethyl maleimide sensitive factor adaptor protein receptor
(SNARE) complex that is critical for calcium-dependent exocytosis during neurotransmission. Pep80 inhibited Ca2+ release
from intracellular stores and blocked downstream signaling by direct interruption of the association between Snapin and an
intracellular calcium release channel, the ryanodine receptor (RyR). NFAT signaling was preferentially abolished by Pep80.
Expression of Snapin overcame Pep80-mediated inhibition of Ca2+/NFAT signaling and HIV-1 replication. Furthermore,
Snapin induced HIV-1 replication in primary CD4+ T cells. Thus, through its interaction with RyR, Snapin is a critical regulator
of Ca2+ signaling and T cell activation. Use of the genetically selected intracellular aptamer inhibitors allowed us to define
unique mechanisms important to HIV-1 replication and T cell biology.
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Introduction
T cell activation is essential for productive HIV-1 infection in
primary T cells since essential processes or molecules that permit
HIV-1 replication become readily available following T cell
induction [1,2,3]. This activation process is initiated by the
interaction of the T cell antigen receptor (TCR) with antigen-
derived peptide bound to the major histocompatibility complex
(MHC) on the antigen presenting cells (APC). This cell-cell
interaction activates signaling cascades and leads to the activation
of NFAT, NF-kB, and AP-1, which are involved in regulation
of gene expression important for T cell proliferation and
differentiation.
Calcium is critical for functional immune responses in T cells
[4]. The interaction of antigen/MHC with TCR triggers TCR
engagement and subsequent Ca2+ release from intracellular stores,
such as the endoplasmic reticulum (ER), through inositol 1,4,5
trisphosphate receptor (IP3R) and RyR on the ER membrane.
IP3R is opened by IP3 (inositol 1,4,5 trisphosphate), which is
produced by TCR engagement [5,6]. RyR is operated by a second
messenger, cyclic ADP-ribose (cADPR); its concentration levels
increase after T cell activation through TCR [7]. The depletion of
ER Ca2+ stores activates Ca2+ release-activated Ca2+ (CRAC)
channels in the plasma membrane and induces Ca2+ influx. The
resulting, long-lasting elevation in cytoplasmic Ca2+ concentration
activates Ca2+ signaling pathways, including those mediated by
calcineurin and NFAT, that control T cell activation and
differentiation in the immune response [8].
In this report, we used a dominant effector genetic selection
scheme to select an aptamer, Pep80, that inhibits HIV-1
replication and T cell activation. The target of Pep80 was
identified as Snapin, a synaptosomal-associated protein 25 kDa
(SNAP-25) binding protein. The interaction of SNAP-25 and Ca2+
sensor synaptotagmin-I (Syt-I) is crucial for the release of dense
core vesicles and sensitization of the SNARE complex during
synaptic vesicle exocytosis. Snapin is involved in the modulation of
the interaction between SNAP-25 and Syt-I necessary for the early
synaptic vesicle docking. Snapin is therefore involved in the
neurotransmitter release process and was originally thought to be
exclusively expressed in neurons and located on synaptic vesicle
membranes [9]. Later, it was demonstrated that Snapin is
broadly distributed in many tissues [10] and interacts with
various molecules such as regulators of G-protein signaling 7,
type VI adenylyl cyclase, dysbindin-1, casein kinase 1d, granulo-
cyte colony-stimulating factor receptor, RyRs, Exo70, aiA-
adrenoceptor (aiA-AR), transient receptor potential canonical 6
(TRPC6), and others [11,12,13]. A study of Snapin knock-out
mice demonstrated that Snapin is involved in calcium-dependent,
SNARE-mediated exocytosis and plays an important role in
neurosecretion [14].
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Here we report a novel function of Snapin in immune cells
detected using a specific inhibitor aptamer peptide: Snapin
regulates Ca2+ release from the calcium stores, such as the ER,
by direct interaction with the intracellular calcium release channel,
RyR, resulting in activation of Ca2+-dependent signaling pathways
required for T cell activation. This peptide inhibitor allowed us to
uncover previously unknown functions of Snapin in calcium
regulation and HIV-1 replication in T cells.
Results
Selection of intracellular aptamers that inhibit HIV-1
transcription through NFAT, but not AP-1, signaling
We developed a dominant effector genetic screen for trans-
acting peptides that act upon T cell signaling processes important
to HIV-1 replication. Libraries (.107 different members) of short
peptides (10-mers) were expressed using a retroviral system [15].
We used Jurkat HIV-LTR dipA cells that had been transfected
with a dipA gene driven by the HIV-1 promoter for this screen.
These cells are killed by stimuli that activate HIV-1 long terminal
repeat (LTR) activity such as phytohaemagglutinin (PHA) or
tumor necrosis factor-alpha (TNF-a) [16]. Cells from the Jurkat
HIV-LTR dipA line survive despite PHA treatment if an expressed
peptide blocks signaling that normally leads to HIV-1 promoter
activation [15].
Jurkat HIV-LTR dipA cells were infected with the retrovirus
peptide library. One week after retrovirus transduction, the cells
were stimulated with PHA. This stimulation was repeated six times
at regular intervals over two months. After the sixth PHA
stimulation, we isolated the GFP-positive (peptide-expressing) cells
by flow cytometry. We prepared total cellular DNA from these
surviving cells. Using specific primers, we rescued peptide-
encoding inserts by PCR and subcloned them into the pBMN-
IRES-GFP retrovirus vector. These retroviral supernatants were
transduced into fresh Jurkat HIV-LTR dipA cells as in the original
screen. This verified that several clones, including that encoding
Pep80, were capable of inhibiting HIV-1 transcription.
To begin to understand how these peptides interfered with the
T cell activation processes, we examined signaling pathways
influenced by Pep80. The most critical cis-regulatory elements in
HIV-1 LTR are the kB regulatory elements that can be activated
by NF-kB or NFAT [17,18,19]. Pep80, as well as four control
peptide clones that were picked from the library at random
(Figure 1A), were individually transduced into Jurkat cells using
retroviral delivery, and cells that expressed GFP (co-expressed with
the peptide) were selected by flow cytometry. After culturing the
selected cells, greater than 98% of cells were positive for GFP.
Luciferase reporter plasmids driven either by three tandemly
repeated NFAT binding sites from the IL-2 gene or by three
tandemly repeated NF-kB binding sites from the Igk chain were
transfected into cells expressing peptides. With TNF-a stimulation
we observed comparable luciferase induction of the NF-kB-
specific reporter plasmid in cells expressing the control peptides
and Pep80 (Figure 1B). With PHA plus PMA stimulation, we
observed the expected stimulation of the NFAT-specific reporter
plasmid in cells expressing the control peptides. In cells expressing
Pep80, NFAT-driven induction was completely inhibited
(Figure 1C).
We then examined the effect of Pep80 on the AP-1 signaling
pathway. AP-1 associates with the Rel domain of NFAT, and the
holoprotein complex is critical for T cell activation [20,21]. An
AP-1-specific reporter plasmid (driven by five tandemly repeated
AP-1 binding sites) was transfected into Jurkat cells and Jurkat cells
expressing either control peptides or Pep80. With PHA plus PMA
stimulation, levels of transcriptional activity were similar in Jurkat
cells, Jurkat cells expressing control peptides, and Jurkat cells
expressing Pep80 (Figure 1D). These results indicate that the
inhibition of the NFAT signaling pathway by Pep80 does not
involve inhibition of AP-1 activation; this was expected based on
earlier work that indicated that AP-1 is a fundamental part of the
NFAT holoprotein complex [20,21]. Pep80 thus specifically
inhibits the NFAT signaling pathway and the target host-cell
molecule of Pep80 is a critical factor in the NFAT-specific
signaling pathway.
Aptamer inhibition of HIV-1 replication
The screen was devised to select inhibitors of early events in T
cell activation on which HIV-1 depends for its replication. We
therefore examined whether Pep80 influenced HIV-1 replication
in T cells. We prepared SupT1 clones expressing either control
peptides or Pep80. SupT1 cells and SupT1 peptide-expressing
cells were challenged by the HIV-1 T-tropic strain NL4-3. Over a
time course of 12 days post HIV-1 challenge, HIV-1 replication
was measured using a p24 ELISA. The HIV-1 replication level
was similar in SupT1 cells and in those cells expressing the control
peptides. In cells expressing Pep80, however, HIV-1 replication
was strongly inhibited at every time point analysed over the time
course of 12 days (Figure 2). This shows that Pep80 inhibits HIV-1
replication in T cells and suggests that the target molecule of
Pep80 might be involved in HIV-1 replication.
Snapin is the target of Pep80
To characterize the mechanism by which Pep80 acts, we
identified the target molecule in host cells using a standard yeast
two-hybrid screen. Pep80 was cloned into a yeast two-hybrid
vector and a leukocyte-derived cDNA library was screened. Of
eight cDNAs selected, four encoded a protein called Snapin.
Other cDNAs selected encoded IL-2 receptor, L37 ribosomal
protein, Gemin2, and Zn-15 related zinc finger protein.
To examine whether Snapin overcomes Pep80 inhibition of the
NFAT signaling pathway, we first performed a luciferase reporter
assay using the NFAT-specific reporter plasmid. The NFAT-
specific reporter was transduced into C-Pep1- or Pep80-expressing
Jurkat cells with or without Snapin. With PHA plus PMA
stimulation, NFAT-driven induction was significantly inhibited in
cells expressing Pep80; however, cells expressing both Pep80 and
Snapin showed luciferase levels similar to those of cells expressing
the control peptide C-Pep1 and Snapin (Figure 3A). We also
prepared SupT1 cells that expressed Snapin constitutively in the
presence or absence of Pep80. When challenged with HIV-1
(NL4-3), Snapin expression alone did not alter HIV-1 replication
in SupT1 cells compared to control cells. However, the inhibition
of HIV-1 replication by Pep80 was completely overcome by
Snapin expression (Figure 3B). From these experiments we
concluded that Snapin is a target of Pep80. These experiments
also indicate that Snapin is involved in NFAT signaling and is
necessary for HIV-1 replication.
To determine whether Pep80 specifically binds to Snapin, we
carried out affinity binding experiments using Snapin fused to
glutathione-S-transferase (GST-Snapin) and an HA-tagged Pep80
(HA-Pep80). GST-Snapin and HA-Pep80 were co-transfected into
293T cells, and cell lysates were immunoprecipitated with anti-HA
antibody. Western blotting of the lysates with anti-GST antibody
showed that Snapin specifically associated with Pep80 (Figure 3C).
We confirmed that Pep80 does not bind to GST by using
GST-p65 fusion protein as a negative control (Figure 3C). This
experiment also ruled out the possibility of non-specific binding
between Snapin and the Gal4 DNA-binding domain that can
Snapin Activates Ca2+ Signal and HIV-1 Replication
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result in a false positive in the Gal-4-based yeast two-hybrid
system.
Snapin localizes to the ER membrane in T cells
To examine the expression and localization of Snapin in T cells,
we performed confocal microscopy using an anti-Snapin antibody.
Staining surrounded the nucleus and was localized in cytoplasm in
Jurkat T cells (Figure 4). It was previously shown that Snapin
interacts with fragments of RyR 1, RyR 2, or RyR3 in vitro [12,13].
We hypothesized that Snapin interacts with RyR and regulates
Ca2+ signal in T cells. To examine this hypothesis, we first tested
whether Snapin was expressed on or near the ER membrane
where RyR is mainly located. We performed confocal microscopy
using an anti-calnexin antibody. Calnexin is an ER-resident
chaperone protein, which is used as an ER membrane marker
[22]. The merged data for Snapin (green) and calnexin (red)
showed significant overlap (orange) (Figure 4). This result suggests
that Snapin and RyR co-localize and therefore might interact in T
cells on the ER membrane.
Pep80 inhibits the interaction between Snapin and RyR
in T cells
Next we examined the physical interaction between endogenous
Snapin and RyR with or without Pep80 in Jurkat cells. We
prepared an ER fraction from either C-Pep1- or Pep80-expressing
Jurkat cells, immunoprecipitated using anti-RyR3 antibody or
control rabbit antibody, and immunoblotted with an anti-Snapin
antibody. In the control antibody immunoprecipitate, we detected
a very narrow band in all cells. When an anti-RyR3 antibody was
Figure 1. Pep80 preferentially inhibits the NFAT signaling pathway. (A) The sequences of control peptides and Pep80. (B–D) Luciferase
reporter plasmids (B) p55-IgkLuc, (C) NFAT Luc, and (D) AP-1 were transfected into Jurkat cells with pBMN lacZ as the internal control plasmid. Cells
were treated for 3 hr (8 hr for AP-1) with or without indicated agents (2 mg/ml PHA, 10 ng/ml PMA, and 10 ng/ml TNF-a) prior to measurement of
luciferase activity. The experiments were repeated three times, and the results are plotted with error bars; values shown are the average 6 SE.
Reporter plasmid-transfected cells without treatment were assigned a value of 1 and used to calculate the fold activation. Transfection efficiencies
were normalized to activity of a co-transfected lacZ plasmid.
doi:10.1371/journal.pone.0075297.g001
Figure 2. Pep80 strongly inhibits HIV-1 replication in T cells.
SupT1 cells expressing one of four control peptides or Pep80 were
challenged with HIV-1 (NL4-3) at a dose of 400 TCID50 per 5610
4 cells.
P24gag levels in culture supernatants were assayed from four wells on
the indicated days after infection. P24gag levels were normalized for cell
number using an XTT assay. Data are presented as the average6 SE per
106 cells. Similar results were observed in three independent
experiments.
doi:10.1371/journal.pone.0075297.g002
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used for immunoprecipitation, we observed a clear band from
Jurkat cells and from C-Pep1-expressing Jurkat cells but not in
Pep80-expressing Jurkat cells (Figure 5). The band in Pep80-
expressing Jurkat cells was observed at a similar level when we
used control rabbit antibody. This indicates that Snapin physically
interacts with RyR in T cells and that the Snapin inhibitor peptide
Pep80 disrupts this interaction. This suggests the possibilities that
Snapin regulates Ca2+ release from intracellular stores by
interaction with RyR and that this regulation is critical for NFAT
signaling pathway and T cell activation.
Snapin regulates Ca2+ channel function of RyRs
RyRs regulate Ca2+ release from intracellular stores such as the
ER by TCR/CD3-mediated stimulation [7]. Our screen showed
that Snapin was activated by PHA, which mimics T cell activation
through TCR. We also demonstrated a physical interaction
between Snapin and RyR (Figure 5). We therefore considered the
possibility that Snapin regulates Ca2+ release from intracellular
stores through RyRs after T cell activation by TCR/CD3-
mediated stimulation. By using the calcium-sensing dye indo-1-
AM, the Ca2+ concentration in the cytoplasm of cells can be
measured, and the use of Ca2+-free medium with EGTA allows
measurement of Ca2+ release from intracellular stores [23]. We
also performed the experiment with medium containing Ca2+ to
measure Ca2+ influx as described below.
Cells were suspended in Ca2+-free medium containing 10 mM
EGTA to avoid Ca2+ influx from outside the cells. We took a non-
stimulated baseline reading for 30 seconds, and then cells were
stimulated with anti-CD3 antibody OTK3. We observed similar
intracellular Ca2+ concentrations after OKT3 stimulation in
Jurkat cells and cells expressing the control peptide C-Pep1.
However, the intracellular Ca2+ concentration was significantly
lower in Pep80-expressing Jurkat cells after stimulation (Figure 6A).
These data show that the inhibition of the interaction between
Figure 3. Snapin overcomes the inhibition of NFAT transcription and HIV-1 replication resulting from expression of Pep80. (A) NFAT
Luc reporter plasmids were transfected into Jurkat cells expressing the indicated peptide with pBMN lacZ as the internal control plasmid. Cells were
treated for 3 hr with or without indicated agents (2 mg/ml PHA and 10 ng/ml PMA) prior to measurement of luciferase activity. The experiments were
repeated three times; values shown are the average 6 SE. Untreated Jurkat cells were assigned a value of 1 and data from these cells were used to
calculate the fold activation. Transfection efficiencies were normalized to a co-transfected lacZ plasmid. (B)’pBMN-control IRES-Lyt2a’ or pBMN-Snapin
IRES-Lyt2a’ retrovirus vectors were transduced into SupT1 cells expressing C-Pep1 or Pep80. These cells were challenged with HIV-1 (NL4-3) at a dose
400 TCID50 per 5610
4 cells. P24gag levels in culture supernatants were assayed from four wells on the indicated days after infection. P24gag levels
were normalized to cell number determined using an XTT assay. Data are presented as the average6 SE per 106 cells. Similar results were observed in
three independent experiments. (C) 293T cells were co-transfected with the indicated combinations of expression vectors: HA-Pep80, GST-p65
(control), or GST-Snapin. Cell lysates were immunoprecipitated with anti-HA mAb and immunoblotted with anti-GST mAb. Purified GST-p65 (control)
and GST-Snapin are shown as controls and marked with asterisks.
doi:10.1371/journal.pone.0075297.g003
Figure 4. Snapin interacts with RyR in T cells. Jurkat cells were
immunostained with anti-Snapin antibody and anti-calnexin antibody.
Cells were then examined by confocal microscopy. Z; Reconstructed
three-dimensional structures of Jurkat cells based on Z-stack analysis of
immunostained Snapin (green) and calnexin (red). Nuclei were stained
with DAPI (blue). White arrows indicate co-localization. Bar, 10 mm.
doi:10.1371/journal.pone.0075297.g004
Figure 5. Pep80 inhibits the interaction between Snapin and
RyR in T cells. After crosslinking the ER fraction from Jurkat cells and
from C-Pep-1- or Pep80-expressing Jurkat cells, samples were
immunopreciptated with anti-RyR3 antibody and immunoblotted with
anti-Snapin antibody.
doi:10.1371/journal.pone.0075297.g005
Snapin Activates Ca2+ Signal and HIV-1 Replication
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Snapin and RyR by Pep80 blocks Ca2+ release from intracellular
stores.
When we over-expressed Snapin in cells expressing either C-
Pep1 or Pep80, the intracellular Ca2+ concentration was elevated
relative to cells that expressed either peptide or a control plasmid
that did not express Snapin (Figure 6A). These data indicate that
Snapin is the target molecule for Pep80 and that Snapin is
involved in Ca2+ release from intracellular stores. Snapin
expression likely caused calcium-induced calcium release (CICR)
through RyR.
To confirm that the inhibition of Ca2+ release from intra-
cellular stores by Pep80 depends on TCR/CD3-mediated
signaling, we examined whether Pep80 was involved in Ca2+
store depletion by thapsigargin treatment. Thapsigargin is an
inhibitor of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase
(SERCA) and causes artificial depletion of calcium stores by
inhibiting Ca2+ transport into the ER independently of intracel-
lular Ca2+ release channels [24]. We did not observe a significant
difference in the intracellular Ca2+ concentration after thapsigar-
gin stimulation in Jurkat cells or Jurkat cells expressing either C-
Pep-1 or Pep80 (Figure 6B). As Pep80 did not inhibit calcium
depletion upon thapsigargin stimulation, Snapin only regulates
Ca2+ release from intracellular stores upon TCR-mediated
signaling through intracellular Ca2+ release channels and does
not influence SERCA-related Ca2+ store depletion. However, we
observed that Ca2+ release from intracellular stores after
thapsigargin treatment was distinctly enhanced in Jurkat cells that
over-expressed Snapin and either C-Pep-1 or Pep80 when
Figure 6. Snapin regulates Ca2+ efflux and influx in T cells. (A, B) Indicated cells were suspended in Ca2+-free medium containing 10 mM
EGTA. ‘‘Control’’ indicates control retrovirus, whereas ‘‘Snapin’’ indicates that cells were infected with Snapin-encoding retrovirus. Cells were
transduced with either Pep80 or C-Pep1. Cells were stained with APC-anti-Lyt2a’ and were loaded with indo-1-AM calcium sensor dye. EGTA was
added, and after 30 s (A) OKT3 or (B) thapsigargin was added. The FL5/FL4 ratio (400 nm/510 nm fluorescence emission) was monitored using a flow
cytometer. (C) Cells were suspended in medium containing Ca2+. After 30 s, OKT3 was added. The FL5/FL4 ratio was monitored using a flow
cytometer.
doi:10.1371/journal.pone.0075297.g006
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compared to Jurkat cells or to Jurkat cells expressing a control
vector with either C-Pep-1 or Pep80 (Figure 6B). As Snapin
expression induced CICR after thapsigargin treatment, CICR
through RyR requires Snapin, and Snapin activation is induced by
TCR/CD3-mediated stimulation. Our data rule out induction of
CICR by Snapin though IP3R since thapsigargin treatment
increases the cytoplasmic Ca2+ concentration but does not induce
production of IP3 [6,24], which is necessary for Ca2+ release from
intracellular stores through IP3R.
We next examined whether Snapin is involved in Ca2+ influx in
T cells. We measured the intracellular Ca2+ concentration in indo-
1-loaded cells expressing either C-Pep1 or Pep80 as described
above. In this case, cells were suspended in medium containing
Ca2+. The level of Ca2+ influx was similar between Jurkat cells and
Jurkat cells expressing C-Pep1. Expression of Pep80 inhibited
Ca2+ influx compared with cells that expressed C-Pep1, and this
inhibition by Pep80 was reversed when Snapin was also expressed
(Figure 6C). This indicates that inhibition of Snapin activity by
Pep80 blocks Ca2+ efflux from intracellular stores and influences
Ca2+ influx and confirms that Snapin is the target of Pep80.
Snapin knockdown inhibits Ca2+ influx in T cells
To elucidate the function of Snapin in T cell biology, we
introduced a Snapin-specific small interfering RNA (siRNA) or a
control siRNA into Jurkat cells using the AMAXA nucleofector
apparatus. Real-time PCR was used to evaluate Snapin expression
24 hr and 48 hr after siRNA transduction. The level of Snapin
mRNA was decreased by about 70% by the Snapin-specific
siRNA in comparison with levels in cells transfected with control
siRNA. To examine the effects of Snapin knockdown on Ca2+
efflux from intracellular stores, the intracellular Ca2+ concentra-
tion was measured using indo-1-loaded cells as described above.
The OKT3-induced intracellular Ca2+ release was inhibited by
the knockdown of Snapin (Figure 7A), indicating that Snapin was
involved in Ca2+ release from intracellular stores in T cells. We
also examined whether Snapin regulates Ca2+ influx in indo-1
loaded T cells by flow cytometry. Snapin knockdown blocked
OKT3-induced Ca2+ influx (Figure 7B). Thus, Snapin is an
important player in Ca2+ release from intracellular stores; Snapin
appears to operate through RyR to open the CRAC channel and
allow Ca2+ influx into T cells.
After Ca2+ influx, NFAT is dephosphorylated by calcineurin,
which is activated by Ca2+, and is rapidly translocated into the
nucleus where it activates the gene expression program for T cell
activation [25]. To examine whether Snapin regulates NFAT gene
transcription, we transduced luciferase reporter plasmids driven by
three tandemly repeated NFAT binding sites into Jurkat cells
transduced with either Snapin-specific siRNA or control siRNA.
After PHA plus PMA stimulation, NFAT-specific transcription
activity was observed in control cells but was inhibited in cells
treated with Snapin-specific siRNA (Figure 7C). Thus, the
inhibition of Ca2+ influx by knockdown of Snapin expression
blocks downstream NFAT activation. These data demonstrate that
Snapin plays a crucial role in induction of NFAT-regulated
transcription.
Snapin regulates Ca2+ signaling critical to HIV replication
To test whether Snapin is involved in HIV-1 replication, we
carried out single-round HIV-1 infection using replication
incompetent HIV-1 (HIV-1-Ea); this virus has a retrovirus
ampho-tropic envelope instead of the wild-type HIV-1 envelope.
We transduced Snapin-specific siRNA or control siRNA into
SupT1 cells 24 hr before HIV-1-Ea challenge. We measured
HIV-1 replication by p24 ELISA 48 hr after the challenge. HIV-1
replication was blocked by the Snapin-specific siRNA (Figure 7D).
This demonstrates that Snapin is also critical for HIV-1 replication
in T cells.
Finally, we examined HIV-1 replication in primary CD4+ T
cells with or without ectopic Snapin expression. Snapin-expressing
or control retrovirus was transduced into primary CD4+ T cells.
HIV-1 (NL4-3) was applied to these CD4+ T cells, and HIV-1
replication levels were measured by a p24 ELISA. We did not
observe HIV-1 replication in control retrovirus-transduced
primary CD4+ T cells. However, in primary CD4+ T cells that
expressed Snapin, HIV-1 replication was dramatically induced
without exogenous activation (Figure 8). This shows that HIV-1
replication was induced by Snapin expression in primary CD4+ T
cells. Thus, Snapin is necessary for T cell activation; activation, in
turn, is required for HIV-1 replication in primary CD4+ T cells.
We conclude that Snapin, which is induced by TCR-mediated
activation, facilitates Ca2+ release from intracellular stores by
operating RyR and positively regulates Ca2+ signaling important
to T cell activation and HIV-1 replication.
Discussion
For productive HIV-1 infection in primary T cells there is a
requirement for intracellular signaling pathway activation [1,2,3].
Such signaling induces reverse transcription, nuclear translocation,
integration, and transcription from the HIV-1 promoter
[1,2,3,18,19]. Interestingly, unlike replication in primary T cells,
HIV-1 replication occurs promiscuously in many CD4+ T cell
lines in the absence of exogenous stimulation. It is likely that
critical host factors for HIV-1 replication that are primed during
physiological activation of primary T cells are constitutively active
in these T cell lines [26]. By determining the nature of the
differences that result in HIV-1 replication in certain cells, critical
features of the biology of HIV-1 and potential therapeutic
modalities will be revealed.
We used a genetic screening approach to create peptidic
aptamers that act as biological modifiers, termed dominant
effectors, to block HIV-1 access to host factors required for
effective replication. The system was designed to allow the
identified peptide inhibitors to be used as tools to isolate the host
factors upon which they act. The dominant effector peptide
described here, Pep80, repressed host pathways that are important
for HIV-1 replication in T cell lines. Using this intracellular
genetic selection system we identified Snapin as a host factor that
regulates HIV-1 replication in T cells. We showed that Snapin is
involved in Ca2+ signaling necessary for T cell activation and HIV-
1 replication using the Snapin-specific inhibitor Pep80 and also by
Snapin knockdown experiments.
Ca2+ is an important second messenger that controls various
physiological functions [27,28]. All these processes begin by
induction of Ca2+ release from intracellular Ca2+ stores such as the
ER and the sarcoplasmic reticulum (SR). Upon T cell activation,
Ca2+ is released after IP3 binding to the IP3R or after induction of
second messenger cADPR for RyRs [5,6,7]. Our data indicated
that Pep80 blocks OKT3-mediated store depletion through
intracellular Ca2+ release channels (Figure 6A) but that Pep80
does not influence the inhibition of Ca2+ influx into the ER by
thapsigargin through SERCA (Figure 6B). We also demonstrated
that Snapin directly associates with RyR; this association was
interrupted by Pep80 in Jurkat cells (Figure 5). This shows that the
inhibition of OKT3-mediated store depletion by Pep80 depends
on the interruption of association between RyR and Snapin.
These findings indicate that Snapin is a positive regulator that
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controls Ca2+ release from intracellular stores through RyR by
TCR/CD3-mediated stimulation in T cells.
Moreover, we observed an increase in Ca2+ release from
intracellular stores upon thapsigargin treatment when Snapin was
over-expressed (Figure 6B). Although thapsigargin treatment in
the absence of Snapin increased the cytoplasmic Ca2+ concentra-
tion, CICR through RyR did not occur since thapsigargin-induced
Ca2+ store depletion was not inhibited by Pep80. When Snapin
Figure 7. siRNA-mediated knockdown of Snapin inhibits Ca2+ influx and HIV replication. Jurkat cells that were transfected with Snapin-
specific siRNA or control siRNA were suspended in (A) Ca2+-free medium with 10 mM EGTA or (B) Ca2+-containing medium. After 30 s, OKT3 was
added. The FL5/FL4 ratio was monitored using a flow cytometer. (C) NFAT Luc reporter plasmid and pBMN lacZ were transfected into Jurkat cells that
were transfected with Snapin-specific siRNA or control siRNA. Cells were treated for 3 hr with or without PHA and PMA prior to measurement of
luciferase activity. The experiments were repeated three times; values shown are the average 6 SE. Data from cells without treatment were assigned
a value of 1 and were used to calculate the fold activation. Transfection efficiencies were normalized to a co-transfected lacZ plasmid. (D) SupT1 cells
that were transfected with Snapin-specific siRNA or control siRNA were challenged with replication incompetent HIV-1-Ea. P24gag levels in culture
supernatants were assayed from four wells 48 hr after HIV-1 challenge. P24gag levels were normalized for cell number using XTT assay. Data are
presented as the average 6 SE per 106 cells. Similar results were observed in three independent experiments. * indicates p,0.05 by t test.
doi:10.1371/journal.pone.0075297.g007
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was over-expressed and cells were treated with thapsigargin,
CICR was observed (Figure 6B). This shows that Snapin function
is induced by TCR/CD3-mediated stimulation and is necessary
for CICR. IP3R and RyR are known to affect CICR differently
[6,29]. For IP3R, Ca2+ is necessary, but not sufficient [30]. IP3R-
mediated CICR requires IP3. However, thapsigargin treatment
does not induce IP3. In contrast to IP3R, CICR through RyR is
induced by Ca2+ alone [31]. This indicates that in Snapin-
expressing cells after thapsigargin treatment CICR occurs through
RyR. Our data clearly show that Snapin is necessary for induction
of CICR through RyR and that the association between Snapin
and RyR regulates Ca2+ release from intracellular stores and
ensuing T cell activation and HIV-1 replication. It has been
reported that Snapin interacts with both aiA-AR and TRPC6 and
facilitates Ca2+ influx through the TRPC6 channel after aiA-AR
activation in PC12 cells [11]. In this case, Snapin interacts with
TRPC6 as a receptor-operated Ca2+ channel and regulates aiA-
AR-operated Ca2+influx. Snapin regulates both Ca2+ release from
intracellular stores and Ca2+influx through different Ca2+ channels
such as RyR and TRPC6. There is no obvious homology between
RyR and TRPC6. Therefore, how Snapin regulates different Ca2+
channels remains unclear.
Snapin had not previously been implicated in HIV-1 replication
and T cell activation. Snapin is small: 15 kDa and only 136 amino
acids. Despite this fact, Snapin interacts with a number of
molecules to regulate their functions [12,13]. Snapin binds to the
fragments from all three isoforms of RyRs [13]. Snapin interacts
with the fragment of RyR2 C-terminal region (4596–4752)
containing a single predicted cytosolic loop and a stretch of long
hydrophobic segment that has been proposed to form a putative
transmembrane domain, M7 (4718–4750) [13]. The binding
region for Snapin on RyR is near the channel pore and ion filter
(4820–4829) [32]. Mutation of RyR1 or RyR2 causes functional
disorders of receptors and induces malignant hyperthermia,
central core disease (CCD), catecholaminergic polymorphic
ventricular tachycardia, and arrhythmogenic right ventricular
dysplasia type 2. These disorders are linked to the mutations of the
RyR C-terminal region [33]. For example, mutations of RyR1 C-
terminal region (3916–4973) are often observed in CCD [34], and
mutations of RyR2 C-terminal region (3778–4959) cause inherited
ventricular tachycardia [32]. We demonstrated that the interac-
tion between Snapin and RyR is important for Ca2+ release from
intracellular stores and ensuing Ca2+ signaling in T cells using
Pep80. It is possible that Snapin cannot bind to the C-terminal
region in the mutants of RyRs and cannot, therefore, regulate
Ca2+ efflux from intracellular stores and CICR. More detailed
analysis of the binding between RyRs and Snapin will be required
to determine whether the inability of RyRs to bind Snapin
underlies these disorders.
RyR3 is expressed in many tissues and in T cells and is
abundant in brain, especially hippocampus, corpus striatum, and
diencephalons. It has been reported that Ca2+ dysregulation via
the amplification of CICR through RyR is involved in Alzheimer’s
disease, dementia, and brain aging [35,36,37]. This amplified
CICR through RyR leads to apoptosis, necrotic cell death, and
finally massive cell death in brain. In fact, CICR through RyR in
the hippocampus increases during brain aging [38]; however, the
levels of RyR expression do not change in brain during aging in
normal rats [39]. This suggests that certain regulatory molecules
that control the function of RyR, such as Snapin, could lead to the
amplification of CICR through RyR during aging. The dysreg-
ulation of Snapin during aging might be related to brain
dysfunction. We demonstrate that Snapin is necessary for
induction of CICR through RyR in T cells. Snapin might play a
similar role in brain. Our Snapin-specific inhibitor peptide Pep80
should prove useful in elucidation of the mechanism of Ca2+
dysregulation in aging brains and Alzheimer’s disease.
The expression of Pep80 inhibited Ca2+ release from intracel-
lular stores by TCR/CD3-mediated OKT3 stimulation and
preferentially blocked the downstream signaling through of NFAT
(Figures 1C and 6A). The long-lasting Ca2+ release from
intracellular stores occurs through RyR; this Ca2+ release activates
CRAC channels and leads to long-lasting Ca2+ influx responsible
for NFAT signaling during T cell activation and proliferation
[7,8]. We demonstrated that Ca2+ release from intracellular stores
through RyR is regulated by interaction between Snapin and RyR
and that this Ca2+ release is crucial for NFAT transcription in T
cells. Our results using Pep80 clearly showed that Snapin plays a
critical role in Ca2+ signal-dependent T cell activation by
operating RyR to release Ca2+ from intracellular stores and
induce CICR.
The dominant effector peptide system we developed creates
artificial specific inhibitors of targeted signaling molecules. The
selected peptide inhibitors can be used to elucidate the physiolog-
ical function of their targets. Here we described selection of
peptides that interfere with T cell activation-dependent processes
that support HIV-1 replication. Using the peptide selected, we
identified the host factor involved in HIV-replication and
elucidated a novel function of this host factor, Snapin, in Ca2+




The sequences of C-Pep1 through C-Pep4 and Pep80 were
inserted into pBMN-IRES-GFP using BamH I and Sal I sites. The
Figure 8. Snapin induces HIV-1 replication in primary CD4+ T
cells. pBMN-control-IRES-Lyt2a’ and pBMN-Snapin-IRES-Lyt2a’ retrovi-
rus vectors were transduced into human primary CD4+ T cells. CD4+ T
cells were challenged by HIV-1 (NL4-3) at 400 TCID50 per 1610
5 cells.
P24gag levels in culture supernatants were assayed from four wells on
the indicated days after infection. P24gag levels were normalized for cell
number using an XTT assay. Data are presented as the average6 SE per
106 cells. Similar results were observed in three independent
experiments. N.D.; not detected.
doi:10.1371/journal.pone.0075297.g008
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coding sequence of Snapin was inserted into pBMN-IRES-Lyt2a’
between BamH I and Sal I sites. pEBG-Snapin (GST-Snapin) was
constructed by inserting the cording sequence of the Snapin into
pEBG. The construction of retrovirus peptide library was
described previously [15].
Screening of peptide library and rescue of survivor
peptides
Recombinant retroviruses representing the peptide library were
prepared using the Phoenix Ampho retrovirus packaging cell line
and infected into 36108 Jurkat HIV-LTR dipA cells as described
previously [15,18]. The cells infected with the peptide library were
stimulated with 2 mg/ml PHA six times over a period of 2 months.
During this selection period, cells were cultured in RPMI 1640
containing 2.5% fetal calf serum (FCS). After this selection, GFP-
positive living cells were sorted by flow cytometry, and total
cellular DNA was prepared from these cells using the QIAamp
Blood Kit (QIAGEN). The DNA was amplified by PCR using the
primers 59-AGCTAGATCGCAGTGTGCCACCATG-39 and
59-CTCGAGTCAGTCAGTCA-39. The PCR fragment was
ligated into pBMN-IRES-GFP and this DNA was transformed
into STBL4 electrocompetent E. coli cells (Invitrogen) according to
the manufacturer’s protocol.
Luciferase assay
Jurkat cells and peptide-expressing Jurkat cells were cultured in
RPMI 1640 containing 10% FCS. The luciferase assay was
performed as described previously [18]. Cells (16106) were
transfected with 1 mg of reporter plasmid, 1 mg of indicated
plasmids, and 1 mg pBMN LacZ by FuGENE6 according to the
manufacturer’s protocol (Roche Applied Science). Thirty-six hours
after transfection, cells were treated as indicated and cell extracts
were measured for luciferase activity. LacZ activity was assayed by
standard methods.
HIV infection and p24 assay
SupT1 cells and SupT1 cells expressing indicated peptides were
cultured in RPMI 1640 medium containing 2.5% FCS. HIV-1
infection and p24 assay were performed as described previously
[19]. Cells were infected with HIV-1 by incubating cells with NL4-
3 (for SupT1 cells, 400 TCID50/5610
4 cells; for primary CD4+ T
cells; 400 TCID50/1610
5 cells) in 0.5 mL of culture medium at
37uC for 4 hr. After HIV-1 challenge, cells were washed with
culture medium and plated in five wells in a 48-well plate (for
SupT1 cells, 56104/well; for primary CD4+ T cells, 16105 cells).
Virus replication was measured on the indicated days after HIV-1
challenge by p24 ELISA according to the manufacturer’s protocol
(ZeptoMetrix Corporation). P24gag levels were normalized for cell
number measured using the XTT assay.
Yeast two-hybrid screening
Pep80 was fused in-frame to the Gal4 DNA binding domain
through a three-glycine spacer in pAS2-1 GAL4 plasmid. A
pACT2-human leukocyte library (Clontech) was used for the
screening by the yeast two-hybrid method in Y190 yeast cells as
described [40] with minor modifications (40 mM 3-aminotriazole
was added to medium).
Immunoprecipitation and immunoblotting
To probe the interaction between Snapin and Pep80, 293T
cells were seeded at 1.56106 cells per 60-mm dish in DMEM
containing 10% FCS. Twenty-four hours later, cells
were transfected with 3 mg of indicated plasmids (GST-p65,
GST-Snapin, and HA-Pep80) using the calcium phosphate co-
precipitation technique [18]. Immunoprecipitation and immuno-
blotting were performed as described previously [26]. Two days
later, the cells were lysed for 20 min in ice in buffer containing
10 mM CHAPS, 50 mM NaCl, 20 mM Tris (pH 7.5) and cleared
by centrifugation. The lysates were immunoprecipitated with anti-
HA mAb (clone HA-7, Sigma) and immunoblotted with anti-GST
mAb (G1160, Sigma) and anti-mouse-HRP conjugate (A9044,
Sigma). Blots were visualized with ECL Plus Western Blotting
Detection System (GE Healthcare). GST fusion proteins were
purified over a glutathione S-transferase column according to the
manufacturer’s protocol (Pharmacia).
To detect the interactions between Snapin and RyR3 or Pep80,
Jurkat cells and indicated peptide-expressing Jurkat cells were
cultured in RPMI 1640 containing 5% FCS. After crosslinking by
dithiobis succinimidyl propionate (22585, Pierce), ER purification
was performed with the Endoplasmic Reticulum Isolation Kit
(ER0100, Sigma) according to the manufacturer’s instructions. ER
fractions were lysed in RIPA buffer (20 mM Tris-HCl, 150 mM
NaCl, 1% NP-40, 1% deoxycholate, 0.1% sodium dodecyl sulfate
(SDS)) containing protease inhibitors (1860932, Thermo). Lysates
were pre-cleared 1 hour with Protein G beads (17-0618-01, GE
Healthcare), and then incubated 2 hour with protein G beads
coupling with anti-human RyR3 antibody (ab9082, Millipore) or
control antibody. The beads were washed six times with RIPA
Buffer and were boiled 5 min with sample buffer (50 mM Tris-
HCl, pH 6.8, 2% SDS, 1% bromophenol blue, 10% glycerol, 5%
b-mercaptoethanol). Eluted proteins were resolved by SDS-PAGE,
and western blot analysis was performed using anti-Snapin
antibody (148 002, Synaptic Systems) as primary antibody and
anti-rabbit IgG-HRP (18-8816, eBioscience) as secondary anti-
body. Blots were visualized with ECL Plus Western Blotting
Detection System (NEL103001EA, Perkin Elmer).
Laser scanning confocal microscopy
Cytospin preparations of Jurkat or SupT1 cells were prepared
by centrifugation of 100 ml of cell suspension (56105 cells/ml) at
450 rpm for 7 min in a Shandon Cytospin 2 cytocentrifuge
(Shandon Southern Products Ltd.). The slides were air dried for
20 min and fixed with 4% paraformadehyde for 15 min at room
temperature and were permeabilized in 90% methanol for
15 minutes on ice. Slides were washed (PBS with 1% BSA) to
block background staining and were incubated with 10% donkey
serum in PBS for 1 hr. Slides were washed once in wash buffer.
Snapin was detected using a primary rabbit polyclonal anti-Snapin
antibody (148002, Synaptic Systems) and a DyLightTM488-
conjugated secondary anti-rabbit (711-485-152, Jackson Immu-
noResearch). Calnexin was detected using a primary mouse
monoclonal antibody (SC-80645, Santa Cruz Biotechnology) and
a DyLightTM594-conjugated secondary anti-mouse antibody
(715-515-151, Jackson ImmunoResearch). Antibody stains
were performed at 4uC for 1 hr. Slides were washed three times
in wash buffer. The slides were stained with DAPI and were
coverslipped with Prolong Gold Antifade reagent (Molecular
Probes, Invitrogen).
Cells were visualized by sequential laser excitation using a
Nikon laser scanning confocal microscope (ECLIPSE Ti) and an
oil immersion 606 objective. Images were acquired using
ImageJ (NIH) software and compiled using Adobe Illustrator
CS2. Z-stacks for three-dimensional reconstructions were collected
at 0.25 mm z axis interval and 6.0 mm total height with a 606
objective. Three-dimensional structures of cells stained with
Snapin, calnexin, and DAPI were constructed from Z-stacked
data (ImageJ).
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Intracellular calcium measurements using flow cytometry
The cells were stained with an anti-mouse CD8a antibody
conjugated to PE (PharMingen, 01045B). After cell-surface
staining, the cells were loaded with indo-1-AM (0.3 mM) in
RPMI1640 complete medium containing 0.025% pluronic F-125
and 4 mM probenecid and incubated at 37uC for 30 min. After
the first incubation, the cells were washed and then incubated at
37uC for 30 min in OPTI MEM. After the second incubation, the
cells were washed three times to remove any free dye and were
resuspended in PBS without Ca2+; 1% BSA and 10 mM ethylene
glycol tetraacetic acid (EGTA) were added before flow cytometry
analysis for measurement Ca2+ efflux from intracellular stores.
HBSS with 1% BSA was added for measurement of Ca2+ influx to
approximately 16106 cells/ml. The cytoplasmic Ca2+ was
determined by measurement of the 400 nm/510 nm ratio using
a flow cytometer. The baseline fluorescence of untreated cells was
measured for 30 s, the tube was removed to add 5 mg/ml OKT3
(eBioscience, 16-0037) or 1 mM thapsigargin (Sigma, T9033), and
then flow cytometry analysis was continued.
siRNA-mediated knockdown of Snapin
The Snapin sequence targeted was 59-GACUGAGACGG-
CUAAACCdAdTdT-39 and the scrambled control sequence was
59-CUAAGGCGAACCGUAAACdGdTdT-39. siRNAs were ob-
tained from Sigma and were transfected into T cell lines using an
AMAXA nucleofector apparatus (program U-014, 3 mg of siRNA
per 16107 cells).
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